http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140006903-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31f87c170ea6e478544c388bd11bb684 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2037-0023 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-0015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14248 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00 |
| filingDate | 2012-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e0d0607efb92a84fad1c3dbabb33a2c |
| publicationDate | 2014-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20140006903-A |
| titleOfInvention | Microneedle-containing transdermal patch |
| abstract | Provided is a transdermal patch that can easily deliver a controlled volume of fluid drug compound. More particularly, the patch contains a microneedle assembly configured in a configuration in fluid communication with the drug delivery assembly. The microneedle assembly contains a support and a plurality of microneedles extending outwardly from the support. The microneedle is formed to have one or more channels of specific dimensions such that passive capillary flow drives the flow of the drug compound. The drug delivery system contains a reservoir for the drug compound in fluid communication with the rate controlling membrane that helps control the flow rate of the drug compound by regulating pressure downstream from the reservoir. The release member is also located adjacent to the microneedle and drug delivery assembly. Prior to use, the release member acts as a barrier to the flow of the drug compound to prevent premature leakage. In this way, the patch may initially be provided in a "inert" configuration in which the drug compound is firmly maintained. When releasing the drug compound, the patch can simply be activated by at least partially separating the release member from the drug delivery assembly and the microneedle assembly. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160124646-A |
| priorityDate | 2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 374.